Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gygax

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|October 10, 2017
Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131)Florian Cymer, Marco Thomann, Harald Wegele, et al.
Chimia|December 4, 2023
How Technical Innovations May Help to Prevent Drug Shortages in SwitzerlandDaniel Gygax, Kaspar Eigenmann, Christian Suter, et al.
Chimia|January 5, 2011
Development and characterization of an enzymatic method for the rapid determination of gamma hydroxybutyric acidMichel A Sciotti, Lara Hasan, Andre Scholer, et al.
Anticancer Research|March 9, 2012
Proteomic analysis of exosome-like vesicles derived from breast cancer cellsGemma Palazzolo, Nadia Ninfa Albanese, Gianluca DI Cara, et al.
Plos One|October 16, 2025
Evaluation of nanopore sequencing for increasing accessibility of eDNA studies in biodiverse countriesDaniel Gygax, Sabina Ramirez, Moses Chibesa, et al.
Microbial Genomics|February 12, 2026
Resolving plasmid-encoded carbapenem resistance dynamics and reservoirs in a hospital setting through nanopore sequencingEla Sauerborn, Rhys T White, Anna-Lena Kalteis, et al.
Neuromuscular Disorders : NMD|March 23, 2010
Reverse protein arrays as novel approach for protein quantification in muscular dystrophiesClaudia Escher, Hanns Lochmüller, Dirk Fischer, et al.
Therapeutic Drug Monitoring|November 23, 2011
An enzymatic method to determine γ-hydroxybutyric acid in serum and urineLara Hasan, Thomas M Jermann, Jakob M Weber, et al.
Biochemical Pharmacology|March 15, 2023
Allosteric targeting resolves limitations of earlier LFA-1 directed modalitiesRiccardo V Mancuso, Gisbert Schneider, Marianne Hürzeler, et al.
Applied and Environmental Microbiology|April 24, 2026
Real-time genomic pathogen, resistance, and host range characterization from passive water sampling of wetland ecosystemsAlbert Perlas, Tim Reska, Alberto Sánchez-Cano, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biologicals : Journal of the International Association of Biological Standardization|October 10, 2017
Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131)Florian Cymer, Marco Thomann, Harald Wegele, et al.
Chimia|December 4, 2023
How Technical Innovations May Help to Prevent Drug Shortages in SwitzerlandDaniel Gygax, Kaspar Eigenmann, Christian Suter, et al.
Chimia|January 5, 2011
Development and characterization of an enzymatic method for the rapid determination of gamma hydroxybutyric acidMichel A Sciotti, Lara Hasan, Andre Scholer, et al.
Anticancer Research|March 9, 2012
Proteomic analysis of exosome-like vesicles derived from breast cancer cellsGemma Palazzolo, Nadia Ninfa Albanese, Gianluca DI Cara, et al.
Plos One|October 16, 2025
Evaluation of nanopore sequencing for increasing accessibility of eDNA studies in biodiverse countriesDaniel Gygax, Sabina Ramirez, Moses Chibesa, et al.
Microbial Genomics|February 12, 2026
Resolving plasmid-encoded carbapenem resistance dynamics and reservoirs in a hospital setting through nanopore sequencingEla Sauerborn, Rhys T White, Anna-Lena Kalteis, et al.
Neuromuscular Disorders : NMD|March 23, 2010
Reverse protein arrays as novel approach for protein quantification in muscular dystrophiesClaudia Escher, Hanns Lochmüller, Dirk Fischer, et al.
Therapeutic Drug Monitoring|November 23, 2011
An enzymatic method to determine γ-hydroxybutyric acid in serum and urineLara Hasan, Thomas M Jermann, Jakob M Weber, et al.
Biochemical Pharmacology|March 15, 2023
Allosteric targeting resolves limitations of earlier LFA-1 directed modalitiesRiccardo V Mancuso, Gisbert Schneider, Marianne Hürzeler, et al.
Applied and Environmental Microbiology|April 24, 2026
Real-time genomic pathogen, resistance, and host range characterization from passive water sampling of wetland ecosystemsAlbert Perlas, Tim Reska, Alberto Sánchez-Cano, et al.
Pageof 3